SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-23-001618
Filing Date
2023-06-30
Accepted
2023-06-30 16:33:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422rvmd_06302023.htm SC 13G 275418
2 JOINT FILING AGREEMENT ex991to13g07422rvmd_06302023.htm EX-99.1 8412
  Complete submission text file 0000921895-23-001618.txt   285391
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Subject) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91387 | Film No.: 231062253
SIC: 2836 Biological Products, (No Diagnostic Substances)